期刊文献+

积极开展对胃癌肝转移的多学科团队综合治疗 被引量:13

Multidisciplinary therapy for gastric cancer with fiver metastasis
原文传递
导出
摘要 胃癌肝转移(GCLM)是晚期胃癌患者死亡的主要原因。GCLM以多发性转移居多.且常伴有肝外病变.特别是腹膜转移,其中绝大多数的肝转移灶无法获得根治性切除。目前,治疗GCLM的方法主要包括根治性手术治疗、胃癌姑息性切除、转移灶消融治疗、介入治疗以及全身化疗等。根据GCLM治疗现状以及解放军总医院普通外科的临床实践,对于GCLM患者,应综合分析患者的全身状态、原发胃癌类型及肝转移程度等,以个体化治疗为原则,通过多学科团队合作,开展积极的综合治疗,选择合适的综合治疗方法。 Gastric cancer with liver metastasis (GCLM) is the leading cause of death in patients with advanced gastric cancer. Multiple metastasis was common in GCLM and usually complicated with lesions outside the liver, especially peritoneal metastasis. Most of liver metastasis lesions could not be resected radically. Currently, main treatments for GCLM included radical operation, palliative resection of gastric cancer, ablation of metastatic lesions, intervention and systemic chemotherapy. Based on the current progress in the treatment for GCLM and our clinical experience, the general status of patients, the type of gastric cancer and the degree of liver metastasis should be analyzed, and a cooperative multidisciplinary team (MDT) should be applied to conduct and to choose active and suitable comprehensive treatment for GCLM patients based on individualized therapy principle.
出处 《中华胃肠外科杂志》 CAS CSCD 2014年第2期101-104,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肿瘤 肝转移 综合治疗 Stomach neoplasms Liver metastasis Mu]tidisciplinary treatment
  • 相关文献

参考文献4

二级参考文献21

  • 1Min-Hua Chen Wei Yang Kun Yan Wen Gao Ying Dai Yan-Bin Wang Xiao-Peng Zhang Shan-Shan Yin.Treatment efficacy of radiof requency ablation of 338 patients with hepatic malignant tumor and the relevant complications[J].World Journal of Gastroenterology,2005,11(40):6395-6401. 被引量:25
  • 2梁萍,董宝玮,于晓玲,于德江,冯蕾,高永艳,王旸,肖秋金.超声引导经皮微波消融治疗肝转移癌疗效评价[J].中华医学杂志,2006,86(12):806-810. 被引量:24
  • 3石军,李洁,刘进德,李志霞.射频消融治疗转移性肝癌的疗效观察[J].腹部外科,2007,20(3):150-152. 被引量:5
  • 4Davies J, Chalmers AG, Sue-Ling HM, et al. Spiral computed tomography and operative staging of gastric carcinoma:a comparison with histopatholagical staging. Gut, 1997, 41: 314-319.
  • 5Rice TW. Clinical staging of esophageal carcinoma. CT, EUS,and PET. Chest Surg Clin N Am,2000,10: 471-485.
  • 6Saunders CA, Dussek JE, O'Doherty M J, et al. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg, 1999,67: 790-797.
  • 7Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum, 2000,43: 759-770.
  • 8Burr BM, Humm JL, Kooby DA, et al. Using positron emission tomography with ^18F-FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia, 2001,3: 189-195.
  • 9Davis PW, Perrier ND, Adler L, et al. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg, 2001,67: 582-584.
  • 10Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of eosophageal cancer with ^18f-fluorodeoxyglucose positron emission tomngraphy.AJR, 1997,168: 417-424.

共引文献82

同被引文献81

引证文献13

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部